F
Fulcrum Therapeutics D
D
FULC
5.60000
USD
1.24
(28.44%)
قبل الجلسة
حجم التداول
2,100
الربح لكل سهم
-1
العائد الربحي
-
P/E
-37
حجم السوق
302,284,114
الأخبار المقالات
العنوان: Fulcrum Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.